Changchun Overseas Pharmaceutical Group

Changchun Overseas Pharmaceutical Group is a prominent Chinese pharmaceutical company headquartered in Changchun, Jilin Province. Established in 1988, the group has evolved into a comprehensive enterprise integrating the research, development, production, and marketing of Traditional Chinese Medicines (TCM) and chemical pharmaceuticals. The company's extensive product portfolio features over 100 varieties, with a particular emphasis on treatments for cardiovascular, cerebrovascular, and rheumatic conditions. Its flagship product, the Yishen Juanbi Pill, is widely recognized in China for the treatment of rheumatoid arthritis and related musculoskeletal disorders. Operating under strict GMP standards, the company maintains several modern production lines and a robust domestic distribution network. Changchun Overseas Pharmaceutical Group is designated as a National High-tech Enterprise, reflecting its commitment to integrating traditional therapies with modern manufacturing processes.